用血小板活化因子拮抗剂WEB 2086治疗特发性血小板减少症。 - Suppr | 超能文献

Idiopathic thrombocytopenia treated with Paf-acether antagonist WEB 2086.

作者信息

Lohmann H F, Adamus W S, Meade C J

出版信息

Lancet. 1988 Nov 12;2(8620):1147. doi: 10.1016/s0140-6736(88)90572-7.

DOI:10.1016/s0140-6736(88)90572-7

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Idiopathic thrombocytopenia treated with Paf-acether antagonist WEB 2086.用血小板活化因子拮抗剂WEB 2086治疗特发性血小板减少症。

Lancet. 1988 Nov 12;2(8620):1147. doi: 10.1016/s0140-6736(88)90572-7.

2

PAF-acether-antagonist WEB 2086 for treatment of chronic idiopathic thrombocytopenia.用于治疗慢性特发性血小板减少症的血小板活化因子拮抗剂WEB 2086

Lancet. 1990 Jul 21;336(8708):191-2. doi: 10.1016/0140-6736(90)91727-r.

3

Inhibitory effect of oral WEB 2086, a novel selective PAF-acether antagonist, on ex vivo platelet aggregation.新型选择性血小板活化因子拮抗剂口服WEB 2086对体外血小板聚集的抑制作用

Eur J Clin Pharmacol. 1988;35(3):237-40. doi: 10.1007/BF00558259.

4

The pathophysiological role of PAF in anaphylactic lung reaction in the guinea pig and in endotoxin shock evidenced by the specific PAF-antagonist WEB 2086.血小板活化因子（PAF）在豚鼠过敏性肺反应及内毒素休克中的病理生理作用，由特异性PAF拮抗剂WEB 2086证实。

Prog Clin Biol Res. 1989;308:925-30.

5

Effects of WEB 2086, a novel antagonist of platelet activating factor, in active and passive anaphylaxis.血小板激活因子新型拮抗剂WEB 2086在主动和被动过敏反应中的作用

Immunopharmacology. 1987 Apr;13(2):117-24. doi: 10.1016/0162-3109(87)90048-8.

6

Effect of PAF-antagonists in endotoxin shock--ovine and rat experiments.

Prog Clin Biol Res. 1989;308:931-6.

7

Failure of the platelet-activating-factor antagonist WEB 2086 BS for treatment of chronic autoimmune thrombocytopenia.血小板活化因子拮抗剂WEB 2086 BS治疗慢性自身免疫性血小板减少症失败。

Blut. 1990 Jul;61(1):21-4. doi: 10.1007/BF01739429.

8

Inhibitory effects of the new PAF acether antagonist WEB-2086 on pharmacologic changes induced by PAF inhalation in human beings.新型血小板活化因子拮抗剂WEB-2086对吸入血小板活化因子诱导的人体药理变化的抑制作用。

Clin Pharmacol Ther. 1990 Apr;47(4):456-62. doi: 10.1038/clpt.1990.57.

9

Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock.血小板活化因子新型拮抗剂WEB 2086在内毒素休克中的保护作用

Eur J Pharmacol. 1987 Mar 17;135(2):117-22. doi: 10.1016/0014-2999(87)90602-9.

10

Platelet-activating factor.血小板活化因子

Lancet. 1988;2(8626-8627):1486. doi: 10.1016/s0140-6736(88)90956-7.

引用本文的文献

1

Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086.血小板活化因子受体拮抗剂WEB-2086对人乳腺癌细胞的生长抑制和分化作用

Br J Cancer. 2006 Jun 5;94(11):1637-42. doi: 10.1038/sj.bjc.6603156.

2

Failure of the platelet-activating-factor antagonist WEB 2086 BS for treatment of chronic autoimmune thrombocytopenia.血小板活化因子拮抗剂WEB 2086 BS治疗慢性自身免疫性血小板减少症失败。

Blut. 1990 Jul;61(1):21-4. doi: 10.1007/BF01739429.

3

Platelet-activating factor type activity in plasma from patients with septicemia and other diseases.败血症及其他疾病患者血浆中的血小板激活因子样活性。

Lipids. 1991 Dec;26(12):1381-5. doi: 10.1007/BF02536571.